Aptevo Therapeutics Inc. · NASDAQ:APVO
Aptevo Therapeutics Inc. shareholders
As of Jun 30, 2026, 8 institutions reported holding Aptevo Therapeutics Inc., 2.8% of its shares. Largest: Gsa Capital Partners LLP, Vanguard and Geode Capital. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Aptevo Therapeutics Inc. | Change | Filed |
|---|---|---|---|---|
| Gsa Capital Partners LLP | 21,539 | 1.2% | +1,901 | Aug 6, 2026 |
| Vanguard | 16,855 | 0.94% | no change | Aug 13, 2026 |
| Geode Capital | 10,821 | 0.60% | −2,516 | Aug 12, 2026 |
| UBS | 730 | 0.04% | −2,715 | Aug 13, 2026 |
| Osaic Holdings, Inc. | 360 | 0.02% | no change | Aug 14, 2026 |
| SBI Securities Co., Ltd. | 109 | <0.01% | no change | Jul 23, 2026 |
| Barclays | 31 | <0.01% | new | Aug 14, 2026 |
| Danske Bank A/S | 1 | <0.01% | no change | Aug 10, 2026 |